Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
Enyuan Shang(City University of New York), Markus D. Siegelin(Columbia University Irving Medical Center)
Cited by 18
Related Papers
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
|Journal of Clinical Investigation|2020|204
TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2015|65
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2016|56